We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Monro
MNRO
$383M
| $3.8M | 0.01% |
72,863
+16,237
| +29% | +$921K |
|
1177
Zillow
Z
$7.79B
| $3.78M | 0.01% |
112,393
+4,952
| +5% | +$176K |
|
1178
Enovis
ENOV
$1.68B
| $3.78M | 0.01% |
55,967
+2,962
| +6% | +$197K |
|
1179
Bankunited
BKU
$3.37B
| $3.78M | 0.01% |
101,335
+5,571
| +6% | +$212K |
|
1180
AMN Healthcare
AMN
$1.31B
| $3.77M | 0.01% |
92,989
+26,418
| +40% | +$1.03M |
|
1181
Power Integrations
POWI
$3.38B
| $3.77M | 0.01% |
114,534
+33,652
| +42% | +$1.12M |
|
|
CHS
1182
DELISTED
Chicos FAS, Inc.
CHS
| $3.75M | 0.01% |
264,348
-16,906
| -6% | -$235K |
|
1183
Exponent
EXPO
$3.24B
| $3.75M | 0.01% |
125,760
+28,802
| +30% | +$839K |
|
1184
First Citizens BancShares
FCNCA
$24.9B
| $3.74M | 0.01% |
11,157
+304
| +3% | +$108K |
|
|
FNSR
1185
DELISTED
Finisar Corp
FNSR
| $3.74M | 0.01% |
136,870
+4,797
| +4% | +$147K |
|
1186
Bright Horizons
BFAM
$3.92B
| $3.74M | 0.01% |
51,585
+874
| +2% | +$61.2K |
|
1187
Nexstar Media Group
NXST
$5.82B
| $3.74M | 0.01% |
53,253
+18,222
| +52% | +$1.22M |
|
|
CRZO
1188
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $3.73M | 0.01% |
130,309
+38,129
| +41% | +$1.25M |
|
1189
Korn Ferry
KFY
$4.18B
| $3.73M | 0.01% |
118,584
+31,422
| +36% | +$943K |
|
1190
Watts Water Technologies
WTS
$11.6B
| $3.73M | 0.01% |
59,873
+15,685
| +35% | +$998K |
|
1191
Mercury Systems
MRCY
$5.83B
| $3.71M | 0.01% |
95,133
+39,112
| +70% | +$1.39M |
|
|
WPG
1192
DELISTED
Washington Prime Group Inc.
WPG
| $3.71M | 0.01% |
47,385
+2,598
| +6% | +$218K |
|
|
SAVE
1193
DELISTED
Spirit Airlines, Inc.
SAVE
| $3.7M | 0.01% |
69,769
+5,008
| +8% | +$268K |
|
|
KITE
1194
DELISTED
Kite Pharma, Inc.
KITE
| $3.7M | 0.01% |
47,094
+2,375
| +5% | +$147K |
|
|
IRBT
1195
DELISTED
iRobot
IRBT
| $3.69M | 0.01% |
55,804
+15,852
| +40% | +$938K |
|
1196
Urban Outfitters
URBN
$6.36B
| $3.69M | 0.01% |
155,272
+5,216
| +3% | +$135K |
|
1197
Synaptics
SYNA
$4.19B
| $3.69M | 0.01% |
74,473
+2,310
| +3% | +$124K |
|
|
ENDP
1198
DELISTED
Endo International plc
ENDP
| $3.69M | 0.01% |
330,288
+31,414
| +11% | +$390K |
|
1199
New York Times
NYT
$12.1B
| $3.67M | 0.01% |
255,113
-840
| -0.3% | -$12K |
|
|
DF
1200
DELISTED
Dean Foods Company
DF
| $3.67M | 0.01% |
186,893
+4,737
| +3% | +$92.7K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.